{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T16:46:39Z","timestamp":1794329199476,"version":"4.9.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T00:00:00Z","timestamp":1395187200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/1471-2474-15-93","type":"journal-article","created":{"date-parts":[[2014,3,19]],"date-time":"2014-03-19T00:06:12Z","timestamp":1395187572000},"source":"Crossref","is-referenced-by-count":120,"title":["The active form of MMP-3 is a marker of synovial inflammation and cartilage turnover in inflammatory joint diseases"],"prefix":"10.1186","volume":"15","author":[{"given":"Shu","family":"Sun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Christine","family":"Bay-Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten A","family":"Karsdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Sofie","family":"Siebuhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qinlong","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter P","family":"Maksymowych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thorbj\u00f8rn G","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Henriksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,3,19]]},"reference":[{"key":"2081_CR1","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1016\/S0140-6736(07)60635-7","volume":"369","author":"J Braun","year":"2007","unstructured":"Braun J, Sieper J: Ankylosing spondylitis. Lancet. 2007, 369: 1379-1390. 10.1016\/S0140-6736(07)60635-7.","journal-title":"Lancet"},{"key":"2081_CR2","doi-asserted-by":"publisher","first-page":"3565","DOI":"10.1007\/s00296-011-2237-8","volume":"32","author":"AC Bay-Jensen","year":"2012","unstructured":"Bay-Jensen AC, Leeming DJ, Kleyer A, Veidal SS, Schett G, Karsdal MA: Ankylosing spondylitis is characterized by an increased turnover of several different metalloproteinase-derived collagen species: a cross-sectional study. Rheumatol Int. 2012, 32: 3565-3572. 10.1007\/s00296-011-2237-8.","journal-title":"Rheumatol Int"},{"key":"2081_CR3","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1093\/rheumatology\/kei208","volume":"45","author":"CH Chen","year":"2006","unstructured":"Chen CH, Lin KC, Yu DT, Yang C, Huang F, Chen HA, Liang TH, Liao HT, Tsai CY, Wei JC, Chou CT: Serum matrix metalloproteinases and tissue inhibitors of metalloproteinases in ankylosing spondylitis: MMP-3 is a reproducibly sensitive and specific biomarker of disease activity. Rheumatology (Oxford). 2006, 45: 414-420. 10.1093\/rheumatology\/kei208.","journal-title":"Rheumatology (Oxford)"},{"key":"2081_CR4","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1002\/art.20696","volume":"51","author":"C Yang","year":"2004","unstructured":"Yang C, Gu J, Rihl M, Baeten D, Huang F, Zhao M, Zhang H, Maksymowych WP, De KF, Veys EM, Yu DT: Serum levels of matrix metalloproteinase 3 and macrophage colony-stimulating factor 1 correlate with disease activity in ankylosing spondylitis. Arthritis Rheum. 2004, 51: 691-699. 10.1002\/art.20696.","journal-title":"Arthritis Rheum"},{"key":"2081_CR5","doi-asserted-by":"publisher","first-page":"669","DOI":"10.1093\/rheumatology\/kel065","volume":"45","author":"LC Huber","year":"2006","unstructured":"Huber LC, Distler O, Tarner I, Gay RE, Gay S, Pap T: Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford). 2006, 45: 669-675. 10.1093\/rheumatology\/kel065.","journal-title":"Rheumatology (Oxford)"},{"key":"2081_CR6","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/ar113","volume":"2","author":"T Pap","year":"2000","unstructured":"Pap T, Muller-Ladner U, Gay RE, Gay S: Fibroblast biology. Role of synovial fibroblasts in the pathogenesis of rheumatoid arthritis. Arthritis Res. 2000, 2: 361-367. 10.1186\/ar113.","journal-title":"Arthritis Res"},{"key":"2081_CR7","doi-asserted-by":"crossref","first-page":"5625","DOI":"10.1016\/S0021-9258(19)67640-4","volume":"266","author":"JJ Wu","year":"1991","unstructured":"Wu JJ, Lark MW, Chun LE, Eyre DR: Sites of stromelysin cleavage in collagen types II, IX, X, and XI of cartilage. J Biol Chem. 1991, 266: 5625-5628.","journal-title":"J Biol Chem"},{"key":"2081_CR8","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/S0021-9258(18)48387-1","volume":"267","author":"CR Flannery","year":"1992","unstructured":"Flannery CR, Lark MW, Sandy JD: Identification of a stromelysin cleavage site within the interglobular domain of human aggrecan. Evidence for proteolysis at this site in vivo in human articular cartilage. J Biol Chem. 1992, 267: 1008-1014.","journal-title":"J Biol Chem"},{"issue":"Pt 2","key":"2081_CR9","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1042\/bj2950581","volume":"295","author":"V Knauper","year":"1993","unstructured":"Knauper V, Wilhelm SM, Seperack PK, DeClerck YA, Langley KE, Osthues A, Tschesche H: Direct activation of human neutrophil procollagenase by recombinant stromelysin. Biochem J. 1993, 295 (Pt 2): 581-586.","journal-title":"Biochem J"},{"key":"2081_CR10","doi-asserted-by":"publisher","first-page":"6351","DOI":"10.1074\/jbc.270.11.6351","volume":"270","author":"SD Shapiro","year":"1995","unstructured":"Shapiro SD, Fliszar CJ, Broekelmann TJ, Mecham RP, Senior RM, Welgus HG: Activation of the 92-kDa gelatinase by stromelysin and 4-aminophenylmercuric acetate. Differential processing and stabilization of the carboxyl-terminal domain by tissue inhibitor of metalloproteinases (TIMP). J Biol Chem. 1995, 270: 6351-6356. 10.1074\/jbc.270.11.6351.","journal-title":"J Biol Chem"},{"key":"2081_CR11","doi-asserted-by":"publisher","first-page":"10261","DOI":"10.1021\/bi00496a016","volume":"29","author":"K Suzuki","year":"1990","unstructured":"Suzuki K, Enghild JJ, Morodomi T, Salvesen G, Nagase H: Mechanisms of activation of tissue procollagenase by matrix metalloproteinase 3 (stromelysin). Biochemistry. 1990, 29: 10261-10270. 10.1021\/bi00496a016.","journal-title":"Biochemistry"},{"key":"2081_CR12","doi-asserted-by":"publisher","first-page":"1544","DOI":"10.1074\/jbc.271.3.1544","volume":"271","author":"V Knauper","year":"1996","unstructured":"Knauper V, Lopez-Otin C, Smith B, Knight G, Murphy G: Biochemical characterization of human collagenase-3. J Biol Chem. 1996, 271: 1544-1550. 10.1074\/jbc.271.3.1544.","journal-title":"J Biol Chem"},{"key":"2081_CR13","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1161\/01.RES.0000070112.80711.3D","volume":"92","author":"R Visse","year":"2003","unstructured":"Visse R, Nagase H: Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res. 2003, 92: 827-839. 10.1161\/01.RES.0000070112.80711.3D.","journal-title":"Circ Res"},{"key":"2081_CR14","doi-asserted-by":"publisher","first-page":"5783","DOI":"10.1021\/bi00476a020","volume":"29","author":"H Nagase","year":"1990","unstructured":"Nagase H, Enghild JJ, Suzuki K, Salvesen G: Stepwise activation mechanisms of the precursor of matrix metalloproteinase 3 (stromelysin) by proteinases and (4-aminophenyl)mercuric acetate. Biochemistry. 1990, 29: 5783-5789. 10.1021\/bi00476a020.","journal-title":"Biochemistry"},{"key":"2081_CR15","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1042\/bj2540731","volume":"254","author":"Y Okada","year":"1988","unstructured":"Okada Y, Harris ED, Nagase H: The precursor of a metalloendopeptidase from human rheumatoid synovial fibroblasts. Purification and mechanisms of activation by endopeptidases and 4-aminophenylmercuric acetate. Biochem J. 1988, 254: 731-741.","journal-title":"Biochem J"},{"key":"2081_CR16","doi-asserted-by":"crossref","first-page":"563","DOI":"10.5858\/2007-131-563-SLOMMS","volume":"131","author":"A Kobayashi","year":"2007","unstructured":"Kobayashi A, Naito S, Enomoto H, Shiomoi T, Kimura T, Obata K, Inoue K, Okada Y: Serum levels of matrix metalloproteinase 3 (stromelysin 1) for monitoring synovitis in rheumatoid arthritis. Arch Pathol Lab Med. 2007, 131: 563-570.","journal-title":"Arch Pathol Lab Med"},{"key":"2081_CR17","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1093\/rheumatology\/38.11.1081","volume":"38","author":"MD Posthumus","year":"1999","unstructured":"Posthumus MD, Limburg PC, Westra J, Cats HA, Stewart RE, van Leeuwen MA, van Rijswijk MH: Serum levels of matrix metalloproteinase-3 in relation to the development of radiological damage in patients with early rheumatoid arthritis. Rheumatology (Oxford). 1999, 38: 1081-1087. 10.1093\/rheumatology\/38.11.1081.","journal-title":"Rheumatology (Oxford)"},{"key":"2081_CR18","doi-asserted-by":"publisher","first-page":"R30","DOI":"10.1186\/ar3734","volume":"14","author":"M Houseman","year":"2012","unstructured":"Houseman M, Potter C, Marshall N, Lakey R, Cawston T, Griffiths I, Young-Min S, Isaacs JD: Baseline serum MMP-3 levels in patients with Rheumatoid Arthritis are still independently predictive of radiographic progression in a longitudinal observational cohort at 8\u00a0years follow up. Arthritis Res Ther. 2012, 14: R30-10.1186\/ar3734.","journal-title":"Arthritis Res Ther"},{"key":"2081_CR19","doi-asserted-by":"publisher","first-page":"1846","DOI":"10.1002\/art.22589","volume":"56","author":"WP Maksymowych","year":"2007","unstructured":"Maksymowych WP, Landewe R, Conner-Spady B, Dougados M, Mielants H, van der TH, Poole AR, Wang N, van der HD: Serum matrix metalloproteinase 3 is an independent predictor of structural damage progression in patients with ankylosing spondylitis. Arthritis Rheum. 2007, 56: 1846-1853. 10.1002\/art.22589.","journal-title":"Arthritis Rheum"},{"key":"2081_CR20","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1002\/art.1780360207","volume":"36","author":"LS Lohmander","year":"1993","unstructured":"Lohmander LS, Hoerrner LA, Lark MW: Metalloproteinases, tissue inhibitor, and proteoglycan fragments in knee synovial fluid in human osteoarthritis. Arthritis Rheum. 1993, 36: 181-189. 10.1002\/art.1780360207.","journal-title":"Arthritis Rheum"},{"key":"2081_CR21","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.cyto.2007.06.001","volume":"38","author":"H Hulejova","year":"2007","unstructured":"Hulejova H, Baresova V, Klezl Z, Polanska M, Adam M, Senolt L: Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine. 2007, 38: 151-156. 10.1016\/j.cyto.2007.06.001.","journal-title":"Cytokine"},{"key":"2081_CR22","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/0009-8981(92)90105-Y","volume":"211","author":"K Obata","year":"1992","unstructured":"Obata K, Iwata K, Okada Y, Kohrin Y, Ohuchi E, Yoshida S, Shinmei M, Hayakawa T: A one-step sandwich enzyme immunoassay for human matrix metalloproteinase 3 (stromelysin-1) using monoclonal antibodies. Clin Chim Acta. 1992, 211: 59-72. 10.1016\/0009-8981(92)90105-Y.","journal-title":"Clin Chim Acta"},{"key":"2081_CR23","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/j.clinbiochem.2010.03.012","volume":"43","author":"N Barascuk","year":"2010","unstructured":"Barascuk N, Veidal SS, Larsen L, Larsen DV, Larsen MR, Wang J, Zheng Q, Xing R, Cao Y, Rasmussen LM, Karsdal MA: A novel assay for extracellular matrix remodeling associated with liver fibrosis: An enzyme-linked immunosorbent assay (ELISA) for a MMP-9 proteolytically revealed neo-epitope of type III collagen. Clin Biochem. 2010, 43: 899-904. 10.1016\/j.clinbiochem.2010.03.012.","journal-title":"Clin Biochem"},{"key":"2081_CR24","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/BF01551818","volume":"3","author":"ML Gefter","year":"1977","unstructured":"Gefter ML, Margulies DH, Scharff MD: A simple method for polyethylene glycol-promoted hybridization of mouse myeloma cells. Somatic Cell Genet. 1977, 3: 231-236. 10.1007\/BF01551818.","journal-title":"Somatic Cell Genet"},{"key":"2081_CR25","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1016\/j.clinbiochem.2011.01.001","volume":"44","author":"AC Bay-Jensen","year":"2011","unstructured":"Bay-Jensen AC, Liu Q, Byrjalsen I, Li Y, Wang J, Pedersen C, Leeming DJ, Dam EB, Zheng Q, Qvist P, Karsdal MA: Enzyme-linked immunosorbent assay (ELISAs) for metalloproteinase derived type II collagen neoepitope, CIIM\u2013increased serum CIIM in subjects with severe radiographic osteoarthritis. Clin Biochem. 2011, 44: 423-429. 10.1016\/j.clinbiochem.2011.01.001.","journal-title":"Clin Biochem"},{"key":"2081_CR26","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1002\/art.37843","volume":"65","author":"AC Bay-Jensen","year":"2013","unstructured":"Bay-Jensen AC, Karsdal MA, Vassiliadis E, Wichuk S, Marcher-Mikkelsen K, Lories R, Christiansen C, Maksymowych WP: Circulating citrullinated vimentin fragments reflect disease burden in ankylosing spondylitis and have prognostic capacity for radiographic progression. Arthritis Rheum. 2013, 65: 972-980. 10.1002\/art.37843.","journal-title":"Arthritis Rheum"},{"key":"2081_CR27","doi-asserted-by":"crossref","first-page":"14245","DOI":"10.1016\/S0021-9258(18)67011-5","volume":"261","author":"Y Okada","year":"1986","unstructured":"Okada Y, Nagase H, Harris ED: A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. Purification and characterization. J Biol Chem. 1986, 261: 14245-14255.","journal-title":"J Biol Chem"},{"key":"2081_CR28","doi-asserted-by":"publisher","first-page":"3404","DOI":"10.1002\/art.11333","volume":"48","author":"W Hui","year":"2003","unstructured":"Hui W, Rowan AD, Richards CD, Cawston TE: Oncostatin M in combination with tumor necrosis factor alpha induces cartilage damage and matrix metalloproteinase expression in vitro and in vivo. Arthritis Rheum. 2003, 48: 3404-3418. 10.1002\/art.11333.","journal-title":"Arthritis Rheum"},{"key":"2081_CR29","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1136\/ard.48.8.645","volume":"48","author":"Y Okada","year":"1989","unstructured":"Okada Y, Takeuchi N, Tomita K, Nakanishi I, Nagase H: Immunolocalization of matrix metalloproteinase 3 (stromelysin) in rheumatoid synovioblasts (B cells): correlation with rheumatoid arthritis. Ann Rheum Dis. 1989, 48: 645-653. 10.1136\/ard.48.8.645.","journal-title":"Ann Rheum Dis"},{"key":"2081_CR30","doi-asserted-by":"publisher","first-page":"3719","DOI":"10.1242\/jcs.00063","volume":"115","author":"AH Baker","year":"2002","unstructured":"Baker AH, Edwards DR, Murphy G: Metalloproteinase inhibitors: biological actions and therapeutic opportunities. J Cell Sci. 2002, 115: 3719-3727. 10.1242\/jcs.00063.","journal-title":"J Cell Sci"},{"key":"2081_CR31","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/0014-5793(86)81074-2","volume":"209","author":"TE Cawston","year":"1986","unstructured":"Cawston TE, Mercer E: Preferential binding of collagenase to alpha 2-macroglobulin in the presence of the tissue inhibitor of metalloproteinases. FEBS Lett. 1986, 209: 9-12. 10.1016\/0014-5793(86)81074-2.","journal-title":"FEBS Lett"},{"key":"2081_CR32","doi-asserted-by":"crossref","first-page":"11539","DOI":"10.1016\/S0021-9258(18)80094-1","volume":"264","author":"L Sottrup-Jensen","year":"1989","unstructured":"Sottrup-Jensen L: Alpha-macroglobulins: structure, shape, and mechanism of proteinase complex formation. J Biol Chem. 1989, 264: 11539-11542.","journal-title":"J Biol Chem"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-15-93.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/1471-2474-15-93\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-15-93","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/1471-2474-15-93.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:04:57Z","timestamp":1648613097000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/1471-2474-15-93"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,19]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["2081"],"URL":"https:\/\/doi.org\/10.1186\/1471-2474-15-93","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.718317356.793496681","asserted-by":"object"}]},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,19]]},"article-number":"93"}}